C-L9PXNADMED
NAD measurement, glutathione measurement, enzymatic assay
diagnostics
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-L9PX
C-L9PXC-L9PXNAD measurement, glutathione measurement, enzymatic assay
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Sponsors | Longevity Summit Dublin 2026 Sponsors | Longevity Summit Dublin 2026 Sponsors on Longevity Summit Dublin 2026. The official website for the Longevity Summit Dublin 2026, a premier science-led. Pages Volunteers — Volunteers on Longevity Summit Dublin 2026. The official website for the Longevity Summit Dublin 2026, a premier science-led. Admin Profile Photos — Admin Profile Photos on Longevity Summit Dublin 2026. The official website for the Longevity Summit Dublin 2026, a premier science-led. Partners — Partners on Longevity Summit Dublin 2026. The official website for the Longevity
Sponsors | ARDD2025 Main Past events ARDD 2025 ARDD 2024 XPRIZE Healthspan Team Summit 2024 ARDD 2023 ARDD 2022 About Speakers Speakers 2026 Speakers 2025 Speakers 2024 Speakers 2023 Speakers 2022 Program Main Track Longevity Medicine Track Emerging Science & Technologies Workshop Physics in Aging Biology Startup Pitch Replacement in Aging Workshop Molecular Nutrition Workshop ARDD Tracks Sponsorship Sponsorship Brochure Sponsors 2025 Sponsors 2024 Sponsors 2023 Sponsors 2022 Media Scam Warning Photos Videos Media Kit Photos 2025 Photos 2024 Photos 2023 Photos 2022 Vid
ITIC Americas Sponsors - International Travel & Health Insurance Conferences Skip to main content International Travel & Health Insurance Conferences = 1024) {navOpen=false;}" x-on:keydown.tab="if (navOpen) trapKeyboardFocus($event);" > Conferences Toggle submenu for Conferences Global Americas MEA UK APAC Previous events Global Americas MEA UK APAC Previous events Sponsor & Exhibit News About ITIJ Awards Subscribe Join our mailing list Stay in the loop, get event launches, speaker announcements, and insider updates straight to your inbox – don’t miss a thing! ITIC Americas , Carta
NADMED Named Tier 4 Sponsor for ARDD 2025 HOME NEWS EXPLORE CAREER Companies Jobs EVENTS iGEM News Team PHOTOS VIDEO WIKI BLOG COMMUNITY FACEBOOK INSTAGRAM TWITTER Thursday, June 25, 2026 No Result View All Result Login HOME NEWS EXPLORE CAREER Companies Jobs Lecturer PhD Studentship Postdoc Research Assistant EVENTS iGEM News Team PHOTOS VIDEO WIKI BLOG COMMUNITY FACEBOOK INSTAGRAM TWITTER HOME NEWS EXPLORE CAREER Companies Jobs Lecturer PhD Studentship Postdoc Research Assistant EVENTS iGEM News Team PHOTOS VIDEO WIKI BLOG COMMUNITY FACEBOOK INSTAGRAM TWITTER No Result View All Result No Res … ass Lock-In Limit June 25, 2026 POPULAR NEWS Saying Goodbye to PGY-6: Pediatric Fellowship Realities 103 shares Share 41 Tweet 26 Multi-Hospital Study Reveals Long Covid Burden Is Twice as High as Current Estimates 92 shares Share 36 Tweet 23 Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks 77 shares Share 31 Tweet 19 New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer 58 shares Share 23 Tweet 15
The NAD Dash: Making Longevity a Measurable Science - Bioanalysis Zone Skip to main content Bioanalysis Zone is part of Taylor & Francis Group. Taylor & Francis About us Our journals Our Digital Hubs Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK. Taylor & Francis Home Awards Events Features An Author's Perspective Ask the Experts bioanalysis articles depth-1 menu-item menu-item-type-post_type menu-item-objec … tial Alzheimer’s diagnostic tool 11 NOV 2025 INTERVIEWS Bioanalysis Rising Star Award: an interview with the 2025 winner 24 OCT 2019 CLINICAL New rapid blood test could identify active tuberculosis infections About Accessibility Advertising & Sponsorship Editorial Policies Permissions & Content Ownership Policy Whitelist Emails Zone Leaders Contact Contact Us Office info Bioanalysis Zone is powered by Taylor & Francis Group Bioanalysis Zone, 2-4 Park Square, Milton
Dynamics of blood NAD and glutathione in health, disease, aging and under NAD-booster treatment | bioRxiv Skip to main content Home About Submit ALERTS / RSS Search for this keyword Advanced Search New Results Dynamics of blood NAD and glutathione in health, disease, aging and under NAD-booster treatment View ORCID Profile Liliya Euro , View ORCID Profile Kimmo Haimilahti , Sonja Jansson , View ORCID Profile Saara Forsström , Jana Buzkova , View ORCID Profile Anu Suomalainen doi: https://doi.org/10.1101/2025.02.24.639825 Liliya Euro 1 Research Programs Unit, Stem Cells and Metabolism Research … ing Interest Statement The NADMED redox profiling method is a subject of patent application WO 2022/008802 (Euro and Suomalainen-Wartiovaara, 2022, 2023a, 2023b; Euro and Suomalainen-Wartiovaara, 2023). L.E., J.B. and A.S., are cofounders of NADMED Ltd; L.E., J.B., S.J., and S.F. are employed by NADMED Ltd. K.H. has received consultancy fee from NADMED Ltd. Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to displa
NADMED Ltd. COO Jana Buzkova interviewed in the Evening Standard. Folks, remember to measure before supplementing! | NADMED Ltd. LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue t
🇫🇮 NADMED raises €3.5m to bring NAD tests to international markets, advancing personalized treatment options - ArcticToday Skip to content subscribe to our newsletter --> Sign In/Get Passport no btn SECTIONS MY ACCOUNT Home Business Technology Shipping Tourism Energy Travel Geopolitics Environment Countries Sweden Norway Finland Iceland USA Canada Denmark Greenland Russia About Us Arctic Studios --> Sign In/Get Passport no btn subscribe to our newsletter --> Sign In/Get Passport no btn subscribe to our newsletter Home Business Technology Shipping Tourism Energy Travel Geopolitics Environment … nd, 2024) – Finnish biotech company NADMED has closed a €3.5M series A round to fund its entry into the U.S. and other international markets with its proprietary nicotinamide adenine dinucleotide (NAD) measurement technology that may help clinicians establish more precise and personalized treatments for various diseases. The round was led by Finnish science-based startup investor Nordic Science Investments (NSI). Additional funding was secured from previous investors Voima Ve … niversity of Helsinki Funds, from a number of private European investors, and a grant from Business Finland. NADs are crucial molecules found in every cell of the body, playing a vital role in energy production, cellular repair, and growth, together with glutathiones (a powerful antioxidant in the body). Measuring NAD and glutathione levels is important because imbalances have been reported to be linked to various age-related health conditions, including metabolic disorders,
Nadmed | Biotech Careers Skip to main content Biotech Careers Contact Submit an Employer Contact Add an Employer Search Open main menu Contact Submit an Employer Contact Add an Employer Search Main navigation Careers Job Areas People Articles Videos Biotech Companies Biotech Jobs Business Areas Nadmed Website: Nadmed Business Area(s) Metabolism Description The NAD metabolite extraction system developed by NADMED measures all four NADs and glutathiones (i.e. REDOX metabolites). Company Location(s) Haartmaninkatu 4, Building 14 00290 Helsinki Finland body Sign up for news Contact Us Add an Emplo
PharmiWeb.com – Thank you 1998 – 2026 AFTER TWENTY–EIGHT YEARS Thank you. Thank you for building PharmiWeb.com Since 1998, this community has helped people find opportunities, build careers, and connect across the industry. As we close this chapter, we do so with gratitude and pride in what we created together. For everyone who found an opportunity here, from entry-level roles to VP positions , and everything in between. And for every advertiser, partner, reader, and every member of the PharmiWeb team since 1998. We were there at the beginning of the dot-com era, even beating
Why skin care is essential health care | Mike Glaicar posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s U … rocesses linked to skin health and longevity. This collaboration centers on the application of synthetic biology technologies, aiming to jointly address the challenges of skin aging and develop breakthrough solutions. Together, Bloomage and LG H&H will combine cutting-edge biotech with skincare expertise to create innovative, effective anti-aging solutions for global consumers. #skincare #biotechnology #bloomage #skinlongevity 17 Like Comment Share Copy LinkedIn Facebook
Projects | Spark Finland SPARK Finland About us For You Applying Projects Education Contact Events News FAQ About us For You Applying Projects Education Contact Events News FAQ Projects “A really great program that has enabled several important contacts for our company and helped to grow as a entrepreneur.” Harri, Sartar Therapeutics “Surgify received highly important expert advice and international networks from the SPARK Finland -program. This is the place-to-be for a starting medtech entrepreneur!” SPARKees – our teams See alumni teams Batch: Spring 2026 Click
The MedTech Podcast - Podcast - Apple Podcasts Zoek Home Nieuw Hitlijsten Zoek The MedTech Podcast Karandeep Singh Badwal 0,0 (0) Levenswetenschappen Tweemaal per week The MedTech Podcast shares the journey behind the path of the people shaping the MedTech industry and its future. Join me as I connect with industry leaders, thought providers and innovators. Hosted by Karandeep Singh Badwal, Karandeep is a Quality & Regulatory Consultant specialising in the MedTech Industry. If you have any ideas for future episodes or would like to be on the podcast then feel free to connect with me via th … ks and has evaluated life science companies for investment at Slater Technology Fund, PureTech Health, KdT and Action Potential Venture Capital. At MindImmune Therapeutics, he is chasing one of the boldest ideas in neuroscience: that Alzheimer's may in fact be an autoimmune disease that presents in the brain. In this episode Isaac explains why the amyloid hypothesis that has dominated Alzheimer's research for 30 years has run its course, and why MindImmune is taking an immuno … der and Managing Partner at Edge Medical Ventures, a medtech venture studio and fund focused on developing and investing in medical devices that address unmet clinical needs. With a BSc in Electrical Engineering from the Technion, an MBA from Columbia Business School and over 25 years building medical device companies, Shai has founded or scaled 18 companies across cardiovascular care, surgery and respiratory health, filing more than 40 patents along the way. In this episode, … e also explore what makes Edge Medical Ventures different from a traditional VC fund. Shai explains how their venture studio model starts from validated unmet needs with a strategic partner already at the table and how their hands-on go-to-market support continues well past the R&D phase. A combination that helped one portfolio company go from zero to FDA approval with distribution agreements and paying customers on just $2.5 million. We also get into the Israeli startup … ology [00:07:53] What a Venture Studio Actually Is and How It Differs From a VC Fund [00:10:51] The $2.5 Million Company That Got FDA Approval and Started Selling [00:13:54] Why Israeli Startups Move Faster Than Everyone Else [00:17:28] How to Think About Patents Without Becoming Obsessed With Them [00:23:44] Balancing Speed and Discipline Withou
ICNMD 2024 - Confirmed Exhibitors - ICNMD 2026 Skip to content ICNMD 2026 #ICNMD2026 SUBSCRIBE TO MAILING LIST Facebook-f X-twitter Linkedin About Message from the President About ICNMD ICNMD 2026 Committees Congress Secretariat Host Venue Related Events & Partners Past Congresses Future Congresses Contact Program CME Accreditation Program at a Glance Onsite Information Scientific Program Presenter Guidelines Call For Abstracts Patient’s Day Teaching Courses Joint Sessions Registration & Accommodation Registration Accommodation Social Events Sponsorship & Exhibits Sponsorship &
What a year it has been. Exactly one year ago, I joined NADMED Ltd. team and landed into the interface of science and business. This spot has turned out to be incredibly rewarding and fulfilling. I… | Henna Uusitalo LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
News > All - [MSC] Mass-Spec-Capital.com - The Mass Spectrometry Web Portal Zum Inhalt News People Events Deals Organisations Newsletter About us Contact Top News Merck Appoints Two Life Sciences Leadership Team Members Genovis Acquires KPL ApS for DKK30.5m Upfront plus Earn-outs Charles River Labs and Medipost Sign Non-Exclusive MOU Brainomix and Boehringer Expand Strategic Partnership in PPF Agilent at Jefferies Global Healthcare Conference 2026 Agilent Names Michael Buckner as Chief Legal Officer Shimadzu Acquires 75% Majority in Plasmion GmbH Merck Launches First Bio-based Solvent Portfoli … t Partners with OmixAI (KR) for AI-Driven Proteomics » More News! » Submit your News! Upcoming Events Metabolomics 2026 Buenos Aires TD Cowen’s Tools/Dx Revolution Conference 2026 Dana Point BIO 2026 San Diego (BIO International Convention) EUROMAR 2026 Gothenburg (Göteborg) bio:cap Investival 2027 Berlin (BioCap 2027) World Health Expo Osaka 2026 (WHX Osaka 2026) DxPx U.S. Conference 2026 Anaheim ADLM 2026 Annual Meeting & Clinical Lab Expo Anaheim Canaccord Genu … 26 Cologne (Köln) PEGS Europe 2026 Lisboa (Lisbon) » More Events! » Submit your Event! Management Appointments Endress+Hauser Appoints Christian Mäder as Future CFO Clara Sattler de Sousa e Brito Joins Merck (DE) from Philips Camila Japur Joins Tecan as CFO on 1 Jun 2026 Birgit Girshick Succeeds Jim Foster as CEO of Charles River Agilent Names Michael Buckner as Chief Legal Officer Kai Beckmann to Succeed Belén Garijo as CEO of Merck KGaA Bruker Appoints Qiagen CE … cks Appoints Darren Sher as Chief Commercial Officer » More News! » Submit your News! Financings & Acquisitions Genovis Acquires KPL ApS for DKK30.5m Upfront plus Earn-outs Alamar Biosciences Closes Upsized $219.9m IPO at Nasdaq Proteins.1 Raises €4.7m in Pre-Seed Funding to Pioneer Omics Shimadzu Acquires 75% Majority in Plasmion GmbH Agilent to Acquire Biocare Medical for $950m in Cash Danaher to Acquire Masimo for $9.9b Total Enterprise Value CubaseBio Receives … naher to Acquire Masimo for $9.9b Total Enterprise Value CubaseBio Receives €2m Grant from EI Transition Programme bioMérieux Acquires Remaining 90% of Accellix for €35m Cash Charles River to Acquire Paris-based PathoQuest Bruker Acquires Remaining 60% Ownership in TOFwerk AG » More News! » Submit your News! Collaborations & Licensing
Apply to KQ Labs accelerator for healthtech startups | Robert Mollen posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree … o main content LinkedIn Top Content People Learning Jobs Games Join now Sign in Apply to KQ Labs accelerator for healthtech startups Robert Mollen 11mo Report this post Founders of UK data driven healthtech and techbio startups should take a close look at the KQ Labs accelerator, hosted by the The Francis Crick Institute . This outstanding programme, supported by the Medicines Discovery Catapult with participation by Cancer Research Horizons , has developed an outstanding net … ertible loan funding We’re proud that KQ Labs alumni have raised £219m to date. Apply today to become part of our thriving ecosystem and meet our alumni on the programme as speakers, mentors, and friends. If you and your company would benefit from joining our programme, we encourage you to apply here today: https://lnkd.in/eHteqjki Any questions? Email [email protected] or join us for an information session in July or August: https://lnkd.in/evcuftJS Application Deadline: 5 … ulations! More info: https://lnkd.in/ejRFDb2c 💡 Join us for the live pitch and award ceremony at the MEDICA INNOVATION FORUM (Hall 12) on November 18th, 15:00–17:00 CET. The finalists will present their innovative solutions, and jury will select winners in each category who will have the chance to win cash prizes of up to €3,500 while gaining valuable exposure to a global network of health tech experts, investors, and media representatives. 💼 Our esteemed expert jury includ … �𝗲𝗮𝗱𝘆 𝘁𝗼 𝗵𝗶𝘁 𝘁𝗵𝗲 𝗯𝗲𝗻𝗰𝗵? -> We admit new cohort members on a rolling basis and can get started today. 𝗞𝗻𝗼𝘄 𝘀𝗼𝗺𝗲𝗼𝗻𝗲 𝘁𝗵𝗮𝘁 𝘀𝗵𝗼𝘂𝗹𝗱 𝗮𝗽𝗽𝗹𝘆? ->Tag them to spread the news. Visit our website, follow-us on LinkedIn, and get in touch today to be part of a new group of pioneers! #SpiraLabs , #HealthTech , #Tec
Why Choose NADMED for NAD & Glutathione Measurement Home Products ALL PRODUCTS Q40 NAD+ & NADH Blood Kit (CE) Q16 NAD+ & NADH Small Blood Kit (CE) Q40 NAD+ & NADH Blood Kit (RUO) Q16 NAD+ & NADH Small Blood Kit (RUO) Q40 NAD+ & NADH Tissue/Cells Kit (RUO) Q40 NADP+ & NADPH Blood Kit (RUO) Laboratory service Science SCIENCE Nadmed Research Further reading Metabolites METABOLITES Clinical applications Why measure WHY MEASURE Clinical applications Partners News Contact Support About Us ABOUT US Media kit Nadmed as Business Why NADMED Key advantages of NADM
Partners & Exhibitors | The Longevity Show 2026 Skip to content Get the latest on the event, plus insights shaping the future of health and longevity, and 15% off your tickets! → What’s On Close What’s On Open What’s On What’s On Explore the speakers, stages and brands shaping how we live better for longer. Get Tickets Stages & SUmmits Headliner Stage Women’s Health Summit Discover Stage Edelman Longevity Lab B2B conference Headliner Stage Women’s Health Summit Discover Stage Edelman Longevity Lab B2B conference The Expo Speakers Evenings The Expo Speakers Evenings Experiences Close Ex … es at-home biomarker testing, wearable device integration, a proprietary mobile application, and one-on-one coaching from certified longevity experts to help clients measurably reduce their biological age. Visit Website Abbott Lingo Rooted in decades of research, Lingo by Abbott is a science-backed CGM that gives you a window into what’s going on in your body by tracking your glucose levels in real time. Knowing what makes your glucose spike can help you make small changes th … ngevita Longevita™ is a doctor-formulated longevity supplement brand founded on award-winning research, by a surgeon and longevity specialist. Our flagship Longevita™ supplement is a complete research backed longevity protocol containing NAD+ precursors and multi-pathway science. Targets cellular health and key healthy ageing pathways. 94% of users have faster recovery, more energy, and skin and gut health results in the first 2 weeks. Visit Website Longevity Clinics Longevit … join their prestigious Inception Program. A winner of the Year 2026 Health 2.0 Award, Reya.ai is an All-in-One Agentic AI-based integrated system of AI Agents, EMR, Biomarkers, Assessments, Wearables, Insights, Appointments, Personalized Health Reports, Workflows, Payments and over 200 other Longevity features. Visit Website Samphire Neuroscience Samphire Neuroscience develops brain-based technologies for women’s health. We translate neuroscience into non-hormonal solutions … te BBC Future World Design (FWD) BBC Future World Design (FWD) is part of Emmy® Award winning BBC’s R&D department that has invented advanced, next-generation media technologies for almost a century. Through data‑driven digital products, intuitive interfaces and creative partnerships, BBC FWD is building the platforms and leveraging eme
CE-Marked NAD Measurement Technology Home Products ALL PRODUCTS Q40 NAD+ & NADH Blood Kit (CE) Q16 NAD+ & NADH Small Blood Kit (CE) Q40 NAD+ & NADH Blood Kit (RUO) Q16 NAD+ & NADH Small Blood Kit (RUO) Q40 NAD+ & NADH Tissue/Cells Kit (RUO) Q40 NADP+ & NADPH Blood Kit (RUO) Laboratory service Science SCIENCE Nadmed Research Further reading Metabolites METABOLITES Clinical applications Why measure WHY MEASURE Clinical applications Partners News Contact Support About Us ABOUT US Media kit Nadmed as Business Groundbreaking technology NADMED answers to demand
More and more, we are seeing academia innovations evolve into start-ups. | Norman Peterson LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to Linked … it still remains lapsed. New applications to the NIH are halted and the January deadline is likely to be eliminated. Active awards are set to end at the close of their current budget year. This no longer feels like just a delay as we wait for congress to ultimately come around - it feels like an intentional decision which will lead to a full-on structural collapse of our innovation economy. This program is one of the only mechanisms in the U.S. that provides non-dilutive capi … ine is now broken. I see this directly: • Pinco Biotherapeutics is preparing to apply this next cycle - if it exists. For early therapeutics, losing SBIRs is an existential threat. • Emerging Innovations Consulting works with academic founders, postdocs, and first-time CEOs who rely on the grants to translate research into companies. Many of them have no alternative funding path that preserves IP control, equity, and scientific independence. • Fulton Bank 's Life Science and … the groundbreaking $50 million Penn-BioNTech Innovative Therapeutics Seed (PxB) Fund, set to revolutionize early-stage life science innovation. This isn't just another investment fund – it's a strategic powerhouse designed to transform cutting-edge university research into life-changing medical solutions. The PxB Fund will: ➡️ Support Penn's most promising scientific discoveries ➡️ Invest in seed and Series A stage companies ➡️ Target breakthrough therapeutics and AI-driven m … ion of high-potential research into patient-benefiting products What makes this fund truly remarkable is its collaborative approach to solving complex medical challenges. With Osage University Partners managing the fund and over $800 million under management, we're witnessing a powerful convergence of academic brilliance and venture capital exper
Instagram Instagram Log In Sign Up Close Never miss a post from meganpormer Sign up for Instagram to stay in the loop. Sign up Log in meganpormer Verified • Follow More options meganpormer Verified Edited • 22w 2016 was the year my real career began. On paper, I was a biomedical engineer and PhD student at Imperial College London. I had chosen a path that made my parents proud and looked impressive. But my heart was already elsewhere. I was drawn to stories, visibility, and the way ideas change people before policies ever do. I didn’t have the language yet, but I knew I wanted to stand at the
NAD & Glutathione Research Papers Home Products ALL PRODUCTS Q40 NAD+ & NADH Blood Kit (CE) Q16 NAD+ & NADH Small Blood Kit (CE) Q40 NAD+ & NADH Blood Kit (RUO) Q16 NAD+ & NADH Small Blood Kit (RUO) Q40 NAD+ & NADH Tissue/Cells Kit (RUO) Q40 NADP+ & NADPH Blood Kit (RUO) Laboratory service Science SCIENCE Nadmed Research Further reading Metabolites METABOLITES Clinical applications Why measure WHY MEASURE Clinical applications Partners News Contact Support About Us ABOUT US Media kit Nadmed as Business Research NAD- and glutathione-related research papers Sugg
NADMED Ltd | HealthBIO 2023 Partnering Event HealthBIO 2023 Partnering Event 7 – 14 Sept 2023 | Finland Home Companies Participants Marketplace Agenda Log in Register Log in Register Log in Register NADMED Ltd StartUP / SME www.nadmed.com/ Helsinki, Finland 9 profile visits About Representatives About After years of study and development, NADMED brings to market a reliable yet simple technology for extracting and measuring all four NADs and two glutathiones. The technology is based on an accurate colorimetric quantification that can be performed even from a minuscule amount of blood. The NADME
News Home Products ALL PRODUCTS Q40 NAD+ & NADH Blood Kit (CE) Q16 NAD+ & NADH Small Blood Kit (CE) Q40 NAD+ & NADH Blood Kit (RUO) Q16 NAD+ & NADH Small Blood Kit (RUO) Q40 NAD+ & NADH Tissue/Cells Kit (RUO) Q40 NADP+ & NADPH Blood Kit (RUO) Laboratory service Science SCIENCE Nadmed Research Further reading Metabolites METABOLITES Clinical applications Why measure WHY MEASURE Clinical applications Partners News Contact Support About Us ABOUT US Media kit Nadmed as Business News NADMED appoints James Lee as CEO NADMED has appointed James Lee as its new Chief Execu … Officer, effective from the beginning of... read more The first $30,000 NADMED Award to Cleveland Clinic We are proud to announce that Dr. Keyue Sun and the Schlegel Lab have been selected as the... read more NADMED Partners with London-based Altheome Labs NADMED has partnered with London-based Altheome Labs to expand access to advanced NAD testing in... read more Could NAD Serve as a Biomarker for Stroke Recovery? A new abstract, presented at the American Stroke Association
Exhibitors - International Travel & Health Insurance Conferences Skip to main content International Travel & Health Insurance Conferences = 1024) {navOpen=false;}" x-on:keydown.tab="if (navOpen) trapKeyboardFocus($event);" > Conferences Toggle submenu for Conferences Global Americas MEA UK APAC Previous events Global Americas MEA UK APAC Previous events Sponsor & Exhibit News About ITIJ Awards Subscribe Join our mailing list Stay in the loop, get event launches, speaker announcements, and insider updates straight to your inbox – don’t miss a thing! ITIC Americas , Cartagena Sponsor
NADMED unlocks the medical and biological potential of NAD metabolites | Helsinki Innovation Services | University of Helsinki Skip to main content For researchers For researchers Invention disclosures Why commercialisation of research matters? Invention rights and protection Funding the commercialisation of research For industry and investors For industry and investors Commercialisation projects Technologies available for licensing Spinout companies Commercialisation Commercialisation Moonshot Studio Contact us News Home Home Close NADMED unlocks the medical and biological potential of NAD me … at can potentially be applied to the diagnostics of a range of diseases." Broad application potential For the purposes of developing and productising the innovation, the researchers established the NADmed team that currently has four members: Academy Professor Anu Wartiovaara acts as a link to the clinic and samples collected from patients with mitochondrial diseases, Liliya Euro is focused on developing the technology, Jana Buzkova serves as the project manager and Sonja Jan … to clinical use, with which all four NAD metabolites can be measured. A patent application pertaining to the core technology of the technique is also pending. “At the moment, we are investigating the significance of the NAD metabolites for various diseases, in cooperation with Finnish biobanks, the Finnish Red Cross Blood Service and a number of other research groups,” says Euro. The researchers believe that there are many areas where a technique measuring NAD metabolites ca … nical laboratories, research institutions, and pharma companies. A patent application for the technology has been filed. Join us We are looking for partners in the pharmaceutical industry to combine our technique with drug screening. We are looking for partners among research groups that are investigating diseases in which NAD metabolites have a significant role. Contact information: Kajsa Kajander, commercial liaison, Helsinki Innovation Services, Jari Närhi, comm … nical laboratories, research institutions, and pharma companies. A patent application for the technology has been filed. Join us We are looking for partners in the pharmaceutical industry to combine our technique with drug screening. We are looking for partners among research groups that are investigating diseases in which NAD metabolites h
NADMED Ltd. | Top Clinical Laboratory Services Company in Europe - 2022 --> --> CLOSE Specials I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info Welcome to Life Science Review! We use cookies and similar technologies to enhance your experience on our website and to provide personalized content and advertisements. By clicking "Accept," you agree to the use of these technologies as described below. You can manage your choices or withdraw consent at any time by visiting our Privacy … within the plant and animal world,” said Euler-Chelpin, who won the 1929 Nobel Prize for Chemistry jointly with Arthur Harden. Recent studies have shown that changes in the levels of NAD+ and its related metabolites (NADome) can indicate the performance of the metabolic function. The challenge, however, lies in measuring the level of NADs as they are difficult to extract from biological fluids, preventing accurate quantitation. NADMED has overcome this challenge by accuratel
NADMED: New way to support diagnoses and care decisions | Helsinki Innovation Services | University of Helsinki Skip to main content For researchers For researchers Invention disclosures Why commercialisation of research matters? Invention rights and protection Funding the commercialisation of research For industry and investors For industry and investors Commercialisation projects Technologies available for licensing Spinout companies Commercialisation Commercialisation Moonshot Studio Contact us News Home Home Close NADMED: New way to support diagnoses and care decisions NADMED was born out … oratories, research institutions, aging clinics, and pharma companies. A patent application for the technology has been filed, protecting the unique method created in the project. Join us We are looking for investors and partners from research and pharma industry. We are also looking for key staff to join the company. Contact information For furher information, please visit . Jari Närhi , CEO NADMED Ltd +358 40 560 33165 Back Commercialisation projects AdCAb AgentFormers
NADMED Ltd. Asset Profile | Preqin Skip to main content Products Our products Preqin Pro Alternative assets data platform Private Markets Research Industry research Term Intelligence Benchmark LPA terms Preqin Benchmarks Industry's leading performance data Preqin Sustainability ESG data and insights Company Intelligence Companies & deals data Enterprise Data Solutions Flexible data delivery solutions Transaction Intelligence A $5.4tn transaction repository Client stories What our clients say Quick Links Our data Asset classes we cover Create a free account Newsletter Contribute data C … r analysis Keep up with market trends Spot new business opportunities Benchmark fund terms Navigate private credit investing Quick Links Our data Asset classes we cover Create a free account Newsletter Contribute data Contact us Insights+ Private markets research Homepage Browse reports Search Search the research library Webinar recordings Join conversations with our analysts Meet the analysts Meet the team behind the reports Learn more Learn more about Private Markets Resear … r analysis Keep up with market trends Spot new business opportunities Benchmark fund terms Navigate private credit investing Insights+ Homepage Search Webinar recordings Meet the analysts Learn more News & content Homepage Events Free Benchmarks Data coverage map Preqin Profiles Preqin Academy Compensation calculator About Who we are Our corporate responsibility Partners Press hub Careers Contact us QuickLinks Our data Asset classes we cover Create a free account Newslett … ed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers. Request demo NADMED Ltd. - overview Established 2022 Location Helsinki, -, Finland Primary Industry Medical Devices & Equipment About Based in Helsinki, Finland, and founded in 2022 by co-founders Jari Narhi (CEO), Jana Buzkova, Liliya Euro, and Anu Wartiovaara MD, NADMED Ltd operates as a provider of advanced meas … alysis and research. In August 2024, NADMED Ltd raised an undisclosed amount of grant funding from Business Finland Venture Capital. The company provides a wide range of laboratory services and measurement products, such as CE-marked assay kits for NAD+ and NADH from whole blood, tissue, or cells, NADP+ and NADPH assay kits, and NAD purity tests.
So proud of Jana Buzkova, my previous PhD student who after defending her thesis progressed to step into developing NADMED Ltd. together with Liliya Euro at the time when we had just an idea, then… | Anu Suomalainen Wartiovaara LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update you
Privacy Policy Home Products ALL PRODUCTS Q40 NAD+ & NADH Blood Kit (CE) Q16 NAD+ & NADH Small Blood Kit (CE) Q40 NAD+ & NADH Blood Kit (RUO) Q16 NAD+ & NADH Small Blood Kit (RUO) Q40 NAD+ & NADH Tissue/Cells Kit (RUO) Q40 NADP+ & NADPH Blood Kit (RUO) Laboratory service Science SCIENCE Nadmed Research Further reading Metabolites METABOLITES Clinical applications Why measure WHY MEASURE Clinical applications Partners News Contact Support About Us ABOUT US Media kit Nadmed as Business Privacy policy GDPR | COOKIES | CONTROLLER INFO Privacy Policy date 21.6.2022 N
- YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
James Lee - NADMED | LSX Nordic Speaker You need to enable JavaScript to run this app. This site is part of the Informa Connect Division of Informa PLC Informa PLC About Us Investor relations Talent This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067. Life Science Executive Partnering 18-19 May 2027 Copenhagen, Denmark Home home Agenda Speakers Investors expand_more Investor Qualification Networking expand_more partneri
Exciting times in NADMED Ltd! Warm welcome to the new CEO, James Lee. Looking forward to your leadership, building on the solid foundation formed by the retiring CEO - Jari Närhi- and the NADMED team. | Anu Suomalainen Wartiovaara LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update
NADMED reveals the secrets of the human body at a metabolic level - Voima Ventures Skip to content Toggle Navigation Home Portfolio Foresight Our Team Submit Pitch Previous Next NADMED reveals the secrets of the human body at a metabolic level October 4, 2022 | Finnish healthtech startup NADMED brings to market a new type of NAD metabolite measurement technology based on an invention created in Professor Anu Wartiovaara’s team at University of Helsinki. After years of rigorous studies, NADMED presents a first-of-a-kind solution which allows more profound and faster study of NADs. In the future … y completed its first financing round of half a million euros, led by deep tech fund Voima Ventures. Other investors include individuals and members of the company’s executive management and board of directors, as well as Kalle Öhman , Venture Partner at Voima Ventures. “NADMED’s test has been developed by one of the globally leading researchers in the field of NAD-metabolism in humans. As the research relating to NADs is continuously growing, we are committed to suppor
NADMED Ltd. will be looking for a new CEO, as Jari Närhi, the appreciated and successful father of our start-up, tells of his retirement plans. Listen here to his words, and stay tuned for the… | Anu Suomalainen Wartiovaara LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your ch
Founder and chairperson of the board at NADMED Ltd - Anu Wartiovaara on Founders Spotlight | Anu Suomalainen Wartiovaara LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join o
The Story Behind NADMED Home Products ALL PRODUCTS Q40 NAD+ & NADH Blood Kit (CE) Q16 NAD+ & NADH Small Blood Kit (CE) Q40 NAD+ & NADH Blood Kit (RUO) Q16 NAD+ & NADH Small Blood Kit (RUO) Q40 NAD+ & NADH Tissue/Cells Kit (RUO) Q40 NADP+ & NADPH Blood Kit (RUO) Laboratory service Science SCIENCE Nadmed Research Further reading Metabolites METABOLITES Clinical applications Why measure WHY MEASURE Clinical applications Partners News Contact Support About Us ABOUT US Media kit Nadmed as Business NADMED Story Story behind NADMED Anu Suomalainen Wartiovaara’s (A
New York Life takes stake in Andera | MedNous Skip to main content 25 June 2026 Last updated: Thursday 25 June 2026 User account anon menu Login Register and subscribe Search Home News News Appointments Events About MedNous Who We Are Editorial Board Editorial Policy Research Directory Research Directory Organisations Interviewees Terms Topics Contact Us Contact Form Menu Breadcrumb Home News New York Life Takes Stake In Andera New York Life takes stake in Andera Wednesday 18 December 2024 Country France New York Life Investments, a US money manager and its European affiliate Candriam, have en
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
NAD Assay Kits & Laboratory Service Home Products ALL PRODUCTS Q40 NAD+ & NADH Blood Kit (CE) Q16 NAD+ & NADH Small Blood Kit (CE) Q40 NAD+ & NADH Blood Kit (RUO) Q16 NAD+ & NADH Small Blood Kit (RUO) Q40 NAD+ & NADH Tissue/Cells Kit (RUO) Q40 NADP+ & NADPH Blood Kit (RUO) Laboratory service Science SCIENCE Nadmed Research Further reading Metabolites METABOLITES Clinical applications Why measure WHY MEASURE Clinical applications Partners News Contact Support About Us ABOUT US Media kit Nadmed as Business Products and Services shop Assay Kits NADMED offers a ra
News - Nadmed Ltd NADMED appoints James Lee as CEO by Kai Herdin | Apr 29, 2026 | News NADMED has appointed James Lee as its new Chief Executive Officer, effective from the beginning of May. His appointment supports the company’s next phase of international growth and expansion. Lee brings over 25 years of experience in global pharma and healthcare,... The first $30,000 NADMED Award to Cleveland Clinic by Kai Herdin | Mar 31, 2026 | News We are proud to announce that Dr. Keyue Sun and the Schlegel Lab have been selected as the inaugural recipients of the NADMED Award for their work on metaboli
MEDICA START-UP COMPETITION Skip to main content Main navigation Close Back --> --> Home Help & Arrival Contact International Representatives Arrival Hotel & CityInfos FAQ Exhibit Trade Fair Participation Online registration Become an exhibitor Stand Cost Calculator Focus topics Trade fair preparations MEDICA HOSPITAL OF THE FUTURE Information Contact persons Download center At a glance Service ABC Hotel & CityInfos Stand constructor portal Traffic regulations Services Fair Match Online-Order-System (OOS) Exhibitor Profile Exhibitor dashboard Scan2Lead Logos & banners Trade fair presence Stand … nefit from free international marketing, visibility across all MEDICA channels, prize money totaling 3,500 euros, networking opportunities with potential investors and business partners, and the chance to exchange ideas with industry experts. Following the event, the MEDICA Start-up Night offers the ideal setting for discussion, networking, and making new connections. The registration deadline for free participation is 10 September, 2026, at 11:59 p.m. Registration for … tration for the MEDICA Start-up COMPETITION Startups, scaleups and SME can also apply for the Healthcare Innovation World Cup . Review: Winners of the 14th MEDICA START-UP COMPETITION 2025 SVAN Medical GmbH 1st place & winner public vote Austria Enables precise and safe surgery through smart drill technology AcroCyte Therapeutics, Inc. 2nd place Taiwan Engineers a comprehensive 3D cell culture technology for patient-derived tumor models Virtuosis AI 3rd place Switzerland Anal … Press Accreditation Press contact Press releases Exhibit Exhibit Exhibit Online Application Online Order System Marketing Services Exhibitor contact Dashboard Parallel event Parallel event Parallel event COMPAMED About MEDICA About MEDICA About MEDICA Product Categories At a glance Newsletter Spheres of MEDICA-Magazine Contact & Support Write to us Hotline +49 211 / 4560-01 FAQs Digital Services Act (DSA) Legal Imprint Privacy Policy Accessibility Compliance Cookie Settings F
News - NOME Programme Portfolio Mentors Partners Corporate Collaborators News Join NOME News from NOME Stay up to date with the latest from the NOME community. Here you’ll find news from our portfolio companies, highlights from recent NOME activities, updates on mentor and partner collaborations, and insights into what’s happening across the Nordic life science ecosystem. Whether it’s a startup breakthrough, a milestone moment, or a behind-the-scenes look at the program—this is where we share it all. Welcome to the pulse of NOME. May 19th, 2026 Saga Diagnostics to be acquired by Roche in trans … on of initial ... View more December 16th, 2025 CurifyLabs wins Productive Idea Award. Portfolio companies NOME portfolio company CurifyLabs has been selected as the winner of the 2025 Productive Idea Award, arranged by Junior Chamber International (JCI). This recognition highlights CurifyLabs’ work in modernising pharmaceutical compounding technology. As part of the award, CurifyLabs was featured in Times Square in New York, and its leadership ... View more October 27th, 202 … 025 Applications Open for the 2025 NOME Startup Competition Startup Competition Apply to the Startup Competition here. The doors are now open for ambitious life science startups from the Nordics, Germany, UK and the Baltics to apply for the 2025 NOME Startup Competition—an exclusive chance to win entry into a prestigious mentoring network, alongside a prize of DKK 50,000 and a wealth of opportunities. Organised annually by ... View more September 1st, 2025 Optheras raises DKK … 2022, and with that, secures a spot in the NOME Mentoring Program and the NOME Prize ... View more November 25th, 2021 Henlez wins NOME Startup Competition 2021 Startup Competition Four life science startups from Denmark, Finland, Norway, and Sweden were invited to pitch in front of 150+ attendance at the NOME Annual Meeting on November 23. After a tight race, Copenhagen-based Henlez wins the NOME Startup Competition 2021, and with that, secures a spot in the NOME Mentoring … tartups from Denmark, Finland, Norway, and Sweden were invited to pitch for the prize of 50 000 DKK and to secure a spot in the NOME Mentoring Program. After a tight race, ... View more November 16th, 2020 Meet the 6 Finalists of NOME Startup Competition 2020 Startup Competition The 6 startups are one step closer to winning access into NOME’s eli
The Science Behind NADMED Home Products ALL PRODUCTS Q40 NAD+ & NADH Blood Kit (CE) Q16 NAD+ & NADH Small Blood Kit (CE) Q40 NAD+ & NADH Blood Kit (RUO) Q16 NAD+ & NADH Small Blood Kit (RUO) Q40 NAD+ & NADH Tissue/Cells Kit (RUO) Q40 NADP+ & NADPH Blood Kit (RUO) Laboratory service Science SCIENCE Nadmed Research Further reading Metabolites METABOLITES Clinical applications Why measure WHY MEASURE Clinical applications Partners News Contact Support About Us ABOUT US Media kit Nadmed as Business Science Behind NADMED Nadmed Research Further reading Non-destructive
Neuroscience News Recap: ONP-002, Isaralgagene Civaparvovec, Azetukalner Trials Advance | Grant Smillie posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Cont … ence News Recap: ONP-002, Isaralgagene Civaparvovec, Azetukalner Trials Advance Grant Smillie 3mo Report this post 🚨🧠 Neuroscience News – 7 day recap: 13/03 ––– 𝘪𝘯 𝘱𝘢𝘳𝘵𝘯𝘦𝘳𝘴𝘩𝘪𝘱 𝘸𝘪𝘵𝘩 World CNS Series 🥼 Clinical News Oragenics, Inc received final ethics approval in Australia to initiate a Ph2a evaluating ONP-002 targeting concussion. Patient enrolment will now commence across three clinical sites Sangamo Therapeutics, Inc. advanced a rolling BLA submission to … ng reduced focal onset seizures by a 42.7% placebo adjusted rate, with plans to submit an NDA to the FDA in Q3 Biogen presented Ph1b data showing salanersen was well tolerated and improved motor outcomes in children with spinal muscular atrophy following prior gene therapy, also announcing the launch of a global Ph3 NMD Pharma A/S reported Ph2a data evaluating ignaseclant showing improved functional outcomes in Charcot-Marie-Tooth disease and was well tolerated Emalex Bioscie … ND enabling of CSM-101, a TRPML1 agonist AcuraStem received a two year research grant from Target ALS to advance programs targeting SYF2 Synuca Therapeutics secured DKK 10M from the BioInnovation Institute (BII) and Lundbeckfonden / Lundbeck Foundation to advance Parkinson’s treatments and complete their lead optimisation Xenon Pharmaceuticals Inc. expect to raise approx. $650M in a public offering Vima Therapeutics extended their Series A to $100M and dosed their first patie … 𝐟𝐨𝐫 𝐚 𝐫𝐚𝐫𝐞 𝐩𝐞𝐝𝐢𝐚𝐭𝐫𝐢𝐜 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 Immusoft announced a $15M grant from the California Institute for Regenerative Medicine (CIRM) to support the clinical development of ISP-001, an engineered B cell therapy for mucopolysaccharidosis type I (MPS I). ISP-001 uses genetically engineered patient B cells as “living biofactories” to
NADMED: NAD & Glutathione Measuring for Laboratories Home Products ALL PRODUCTS Q40 NAD+ & NADH Blood Kit (CE) Q16 NAD+ & NADH Small Blood Kit (CE) Q40 NAD+ & NADH Blood Kit (RUO) Q16 NAD+ & NADH Small Blood Kit (RUO) Q40 NAD+ & NADH Tissue/Cells Kit (RUO) Q40 NADP+ & NADPH Blood Kit (RUO) Laboratory service Science SCIENCE Nadmed Research Further reading Metabolites METABOLITES Clinical applications Why measure WHY MEASURE Clinical applications Partners News Contact Support About Us ABOUT US Media kit Nadmed as Business The Most Advanced Method of NAD and Glu … n every step of the process. The data was delivered well before the anticipated deadline and was of very high quality. I’m sure we will also run our next study with NADMED.” Tim Peterson, CEO, BIOIO Tech ”Nicotinamide adenine dinucleotide (NAD) is essential for cellular energy metabolism, especially in the mitochondria, where it aids in producing ATP, the cell’s primary energy unit. Increasing NAD+ levels and improving the NAD+/NADH ratio through NAD+ precursors h … effective from the beginning of May. His... read more The first $30,000 NADMED Award to Cleveland Clinic We are proud to announce that Dr. Keyue Sun and the Schlegel Lab have been selected as the inaugural recipients of the... read more NADMED Partners with London-based Altheome Labs NADMED has partnered with London-based Altheome Labs to expand access to advanced NAD testing in the UK, marking... read more « Older Entries Subscribe to newsletter Yes, I want to subscri
Introducing Dr. Charles Brenner - Forever curious and passionate for uncharted research questions | University of Helsinki | NADMED Ltd. LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Co
17th Annual Outsourcing in Clinical Trials West Coast 2025 - Arena International --> Home About Us Events Contact Us Why attend? Agenda Advisory Board Speakers Plan Your Visit Event Gallery Sponsors Resources Why partner? Contact Us Download Agenda Registration Closed 17th Annual Outsourcing in Clinical Trials West Coast 2025 Creating a collaborative environment where pharma & biotech leaders can find solutions to current challenges through innovations and partnerships Start 11 Feb End 12 Feb Hyatt Regency San Francisco Airport, Burlingame, CA, USA Registration Closed … r Strategy Manager – FSP, Pfizer 3 PM Afternoon refreshments, networking & prize draw in exhibition room 3:30 PM Speaker Hosted Round Tables Interactive roundtable sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Hosted by industry experts and each focused on a single issue, roundtables are an exciting, interactive way to build your personal network and … rong data analysis and clinical financial reporting capabilities including post RFP analysis, accruals, and forecasting •Successful management of a team •Clinical trial monitoring, regulatory and legal experience •Investigator, Advisory Board and Ad Comm Meeting coordinating experience Session Details: PANEL DISCUSSION: Is clinical trial exclusion criteria too stringent? 2025-02-11, 12:00 PM View In Agenda Next speaker Back Ros Cheetham Vice President of Clinical Operations, … s made groundbreaking contributions to neurology and clinical research. After a fellowship in experimental therapeutics, Dr. Feigin joined North Shore University Hospital as an assistant professor of neurology. There, he set up a clinical trial program for Parkinson’s, Huntington’s, Tourette syndrome, dystonia and other movement disorders. Subsequently, Dr. Feigin joined the NYU Grossman School of Medicine as Professor of Neurology where he directed the Fresco Institute for P … ao brings expertise in clinical outsourcing, strategic vendor partnerships, and RFP process optimization, providing a fresh vision for the organization. Beyond professional achievements, Bao is dedicated to fostering collaboration and investing in the local community. As a partner of The Town FC and a Silicon Valley angel investor, Bao champions
Latest News About Capabilities News suPAR Test NAD Test Resources Contact ')"> About Capabilities News Careers NAD Test Resources Contact ')"> A new step forward for biomarker-driver precision health in the UK. We’re excited to announce our partnership with NADMED Ltd. to bring advanced NAD Testing to clinics, researchers, and healthcare innovators. NAD (NAD⁺ / NADH) is a central metabolic biomarker, directly linked to: - Cellular energy metabolism - Mitochondrial function - DNA repair pathways - Biological ageing and resilience Yet until recently, measuring NAD reliably in clinical and resear
Mitochondria Signaling in Physiology and Disease | Keystone Symposia Sign-in/Account Create Account Cart --> Conferences Digital Pass for Institutions On Demand For Purchase Conference List How to Register Invitation Letter Submit an Abstract Poster Display Guidelines View Abstracts Cancellations and Transfers Submit a Conference Concept Why Participate? Past Conferences Financial Aid Student Discounts Scholarships Global Health Awards Early-Career Travel Awards Financial Aid Portal Login Support Us Current Supporters Media Support Support a Meeting Support in Other Ways Prog … utions On Demand For Purchase Conference List How to Register Invitation Letter Submit an Abstract Poster Display Guidelines View Abstracts Cancellations and Transfers Submit a Conference Concept Why Participate? Past Conferences Financial Aid Student Discounts Scholarships Global Health Awards Early-Career Travel Awards Financial Aid Portal Login Support Us Current Supporters Media Support Support a Meeting Support in Other Ways Program Enrichment Career Accelerators Health … ; In Person On Demand Meeting Summary Why Keystone Symposia? Submit an Abstract Abstract Submission Closed Meeting Deadlines Scholarships/Awards Program Pricing & Registration Spread the Word Lodging Travel Information Venue Information × - Feb 09–12, 2026 | Keystone Resort, Keystone, CO, United States Scientific Organizers: Navdeep S Chandel and Aleksandra Trifunovic Navdeep S Chandel, PhD Northwestern University Navdeep Chandel, Ph.D., is a … cognized for his contributions to biomedical sciences, receiving the 2023 Lurie Prize in Biomedical Sciences. His work continues to impact various fields, including immunology, with direct implications for addressing cancer and metabolic diseases. Dr. Chandel has organized multiple conferences over the past 20 years including Keystone Symposia meetings (2010 Hypoxia, 2014 Tumor Metabolism) and Cell Symposia meetings (2015 Mitochondria, 2022 Metabolite in Signaling and Disease … MBO member in 2024 and received the Max Delbrück University of Cologne Research Award in 2025 for her outstanding contributions to research. She has served on many organizing committees for mitochondrial meetings including the EuroMit 10 meeting in 2017. Available Formats: In Person On Demand Supported by: Lucid S
NADMED appoints James Lee as CEO | James Lee | 80 comments LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement , Privacy Po
Kai Herdin - Integrative and Personalised Medicine 2026 Skip To Main Content REGISTER (opens in a new tab) Register Now (opens in a new tab) Conferences Show submenu for: Conferences Overview Conference Speakers Whole-Person Health Integrative Mental Health Integrative Oncology Food on Prescription Advanced Practitioner Conference Speakers Books Download Conference Programmes PDF Exhibition Show submenu for: Exhibition Exhibitor List Floorplan Sponsorship Opportunities Exhibit at IPM 2025 Attendance Workshops Show submenu for: Workshops Workshop Programme Wall-to-Wall Health Coaching Practitio … ic health. At NADMED, he bridges biochemistry, molecular medicine, and clinical application. Holding an MSc degree in communications and with a prior career outside life sciences, he moved into biotechnology to contribute to a meaningful, health-impacting field. NADMED has proudly partnered with Altheome, a specialist biomarker and diagnostics technology company, to bring advanced NAD testing to clinics and consumers in the UK. Sessions 18-Jun-2026 09:45 &
Voima Ventures: The Early Stage Founder's Guide Superscout Programs App Investors More Browse Opportunities VC Programs Index VC Fellowship Programs VC Scout Programs Become a Scout Apply Superscout App Browse By City Browse By University Browse By Accelerator In-Depth Venture Partner Deal memo Resources Scouts Home Learning Center Glossary Frequently Asked Questions Investors Investors Home Add Your Program Dealflow Hub Knowledge Hub Contact Us Articles VC Scout Programs: All You Need to Know From Scout to VC Partner: How Scouting Became the Fastest Track Into Venture Why Scout Program … w to Navigate Them Become a Scout Browse Opportunities VC Programs Index VC Fellowship Programs VC Scout Programs Become a Scout Apply Superscout App Browse By City Browse By University Browse By Accelerator In-Depth Venture Partner Deal memo Resources Scouts Home Learning Center Glossary Frequently Asked Questions Investors Investors Home Add Your Program Dealflow Hub Knowledge Hub Contact Us Articles VC Scout Programs: All You Need to Know From Scout to VC Partner: How … . Linda oversees the financial operations of Voima Ventures, ensuring effective fund management and compliance. How to Pitch Pitching Tips To pitch to Voima Ventures, founders should reach out via email at [email protected]. It is recommended to include a comprehensive pitch deck that outlines the startup's vision, technology, market opportunity, and team qualifications. Voima Ventures appreciates detailed information that demonstrates the startup's potenti … address significant global challenges through scientific innovation. How can I apply or pitch to Voima Ventures? Founders can pitch their startups by reaching out via email at [email protected]. They should include a detailed deck outlining their business model, market opportunity, and team background. What makes Voima Ventures different from other VCs? Voima Ventures emphasizes scientific innovation and sustainability, with a strong focus on university an … particularly interested in startups based in these regions. What is the typical fund size and check size for investments? Voima Ventures manages a total of €100 million across its funds, with initial investment amounts ranging from €200,000 to €3 million. What kind of post-investment involvement can portfolio companies expect? Voima Ventures prov
Nadmed appoints new CEO | MedNous Skip to main content 25 June 2026 Last updated: Thursday 25 June 2026 User account anon menu Login Register and subscribe Search Home News News Appointments Events About MedNous Who We Are Editorial Board Editorial Policy Research Directory Research Directory Organisations Interviewees Terms Topics Contact Us Contact Form Menu Breadcrumb Home Nadmed Appoints New CEO Nadmed appoints new CEO Monday 18 May 2026 Company Nadmed Ltd Appointee name James Lee Country Finland Nadmed Ltd has appointed James Lee as chief executive officer as the Finnish company scales it
New collaboration with Finnish NADMED Ltd. | Connectem ABOUT WHY CONNECTEM SERVICES TEAM INDUSTRY EXPERTISE IN VITRO DIAGNOSTIC MEDICAL DEVICES Clients CLIENTS TESTIMONIALS NEWS CONTACT Select Page New collaboration with Finnish NADMED Ltd. Mar 20, 2024 | Pharma / Biotech We are excited to collaborate with Finnish NADMED Ltd ., and introduce its new diagnostic kit for measuring NAD+ / NADH-levels in whole blood samples. This test is CE-marked and represents a cost-effective, quick and accurate alternative to mass spectrometry measurement . There is no need to invest in new equipment since stan
Effortless measurement of all four NADs and glutathione for laboratories Home Categories Ingredients Analysis Manufacturing Finance Company News Regulatory Drug Delivery Research & Development Sustainability Pharma 5.0 Events Directory Search Close search Subscribe Login Password Password Remember me Forgot password? Close login form Manufacturing Chemist Home Manufacturing Effortless measurement of all four NADs and glutathione for laboratories Effortless measurement of all four NADs and glutathione for laboratories Published: 2-Feb-2024 Manufacturing In response to the escalating demand
Instagram Instagram Log In Sign Up Close Never miss a post from ebresearchaus Sign up for Instagram to stay in the loop. Sign up Log in ebresearchaus • Follow More options ebresearchaus 50w 25 years of research. One powerful moment. Dr. Jean Tang shares what it took to get to FDA approval of @abeonatherapeutics ZEVASKYN™—the first-ever cell-based gene therapy for RDEB. She opens up about leading the trial during COVID, the decades of lab work that came before, and the patients and families who made it possible. Learn more at https://ow.ly/tjev50WlRbg 🦋 Donate at https://ow.ly/os7b50WlRbc Load
Scaling Outcome-Based Care in Cardiometabolic Disease Prevention | Ben Horner posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, y
$30,000 award up for grabs in metabolomics research - Drug Discovery World (DDW) Drug Discovery World (DDW) About Us | Subscribe Free | Media Info | Contact Us | Log In News Exclusive Content Features Opinion Market Reports Trends & Analysis Start-up Zone DDW eBooks Business & Investment Regulatory Events DDII Events Series Other Events Webinars Resources Magazine Digital Issues Archive Multimedia Videos Podcasts Topic filter: Cancer Research Immunology / Virology & Vaccines Advanced Therapies Neuroscience Multiomics Artificial Intelligence Automation & Robotics Therapeutic Antibodies Micr … Magazine Digital Issues Archive Multimedia Videos Podcasts Home / News $30,000 award up for grabs in metabolomics research 3 December 2025 • By Bruno Quinney • #News Share: Posted in News | Tagged Awards , Drug discovery , Metabolomics Biotechnology company NADMED has launched an award worth $30,000 to accelerate breakthroughs in metabolomics research. The NADMED Award 2026 is a global initiative designed to empower scientific discovery in redox biology and accelerate innova … nd accelerate innovation across medicine, life sciences, and biotechnology. The award aims to enable scientists and clinicians to deepen understanding of key cellular processes linked to metabolism, ag e ing, and disease, areas where accurate measurement has long been a limiting factor. By providing access to NADMED’s advanced metabolomics platform, the initiative supports discovery and collaboration which could shape the next generation of biomedical innovation. “The goal of … uld shape the next generation of biomedical innovation. “The goal of the NADMED Award is to lower the barriers for scientists to explore what has until now been largely invisible in biology: the dynamics of redox metabolism,” said Kai Herdin, Chief Marketing Officer at NADMED. “By making our tools available to the research community, we want to accelerate discoveries that could transform how we understand cellular function and disease.” NADMED was founded in 2022 as a spinout … dized glutathione directly from biological samples, including blood. The NADMED Award 2026 is open to academic institutions, clinical laboratories, pharmaceutical companies, and biotech innovators worldwide. Submissions will be reviewed by a scientific jury of global experts, including Professor Charles Brenner (City of Hope) and Professor Rita H
Another great discussion on the vision of NADMED Ltd., this time at the Global Forum 2026 in Lund hosted by BioStock - Connecting Innovation and Capital. What continues to resonate with those I… | James Lee LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time
New investments, team expansions, and reconnecting with the community - 2022 in a nutshell - Voima Ventures Skip to content Toggle Navigation Home Portfolio Foresight Our Team Submit Pitch Previous Next New investments, team expansions, and reconnecting with the community – 2022 in a nutshell December 20, 2022 | Whew – what a year it’s been! Between the challenging economic environment, the tragic and unjust war in Ukraine and the following energy crisis, and adapting to the somewhat post-covid world, it’s been a busy year. On the bright side, the year featured 6 new portfoli … y through in-person events (finally!). In 2022, we’ve grown into a truly Nordic fund, opening office and recruiting team members in Sweden. The year has been characterized by emerging disruptive technologies in energy storage solutions, bio based materials, quantum and predictive diagnosis in healthcare. Beyond exploring new tech, we’ve focused on bringing value and achieving change through our events and portfolio operations, while leveraging our network to help our founders … ptic and QuantrolOx were the only Finnish companies to receive this prestigious grant. This year’s portfolio company funding rounds also brought on some new exciting co-investors. Adamant Health scored an investment from German pharma giant Gerresheimer , whereas Samsung Ventures led ElFys’ latest funding round. Beyond funding rounds, many of our companies took other big leaps ahead this year. The biggest news by far this year was the incredible 100 million commercial d … he entire startup community for the prestigious recognition. Inka receiving the award at FVCA:s autumn seminar. As we keep pushing for more gender diversity in the deep tech scene, the community keeps delivering. In the search for great women and non-male board members for our portfolio companies, the community provided us with immense support and outstanding recommendations. The efforts culminated in the second-ever Women to Boards event, where we connected non-male experts
Ladakh In The Media | Press Release Health and Wellness Centres to be rebranded as “Tsey-Ring Nadmed Tsonas” in Leh as per the guidelines of Health Ministry.
We welcome 6 new portfolio companies Nordic Science Investments which we did this summer ! Breakthrough science to make a difference. Our strong dealflow shows the experience of our team and the… | Anssi Uimonen LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any
Biotech labs TruDiagnostic and NADMED partner to launch novel NAD+ blood test in United States Accessibility Statement Skip Navigation Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact Search Search When typing in this field, a list of search results will appear and be automatically updated as you type. Searching for your content... No results found. Please change your search terms and try again. News in Focus Browse News Releases All News Releases All Public Company English-only News Releases Overview Multimedia Gallery All Multimedia All Phot … tform Login ProfNet Data Privacy Do not sell or share my personal information : Submit via [email protected] Call Privacy toll-free: 877-297-8921 Contact PR Newswire Products About My Services All News Releases Platform Login ProfNet Call PR Newswire at 888-776-0942 Terms of Use Privacy Policy Information Security Policy Site Map RSS Cookies Copyright © 2026 Cision US Inc. --> -->
%PDF-1.5 %���� 4889 0 obj > endobj xref 4889 29 0000000016 00000 n 0000009839 00000 n 0000009956 00000 n 0000011105 00000 n 0000011144 00000 n 0000011193 00000 n 0000011308 00000 n 0000012054 00000 n 0000012788 00000 n 0000013497 00000 n 0000014203 00000 n 0000014850 00000 n 0000015483 00000 n 0000016291 00000 n 0000016404 00000 n 0000016661 00000 n 0000017371 00000 n 0000017997 00000 n 0000018682 00000 n 0000021333 00000 n 0000041035 00000 n 0000045699 00000 n 0000045756 00000 n 0000047139 00000 n 0000047180 00000 n 0000108296 00000 n 0000113422 00000 n 0000114760 00000 n 0000000876 00000 n t … T14:32:45+02:00 2019-09-24T14:32:45+02:00 Adobe Illustrator CC 23.0 (Macintosh) application/pdf Neuro-SysMed_CMYK_Logo uuid:b8e625f8-f693-954f-a1f3-e51325a3fc6c uuid:150beb27-13bf-1c45-a39e-597feb062452 Adobe PDF library 15.00 endstream endobj 4912 0 obj > endobj 4913 0 obj >stream ����Adobed��� '# #+++ #-%'4/%-7/22B2/7:BBBBB:DDDDDDDDDDDDDDDDDDDDD &.###&3')))'3>344443>;DDDDD;DDDDDDDDDDDDDDDDDDDDD &.###&3')))'3>344443>;DDDDD;DDDDDDDDD … T14:32:45+02:00 2019-09-24T14:32:45+02:00 Adobe Illustrator CC 23.0 (Macintosh) application/pdf Neuro-SysMed_CMYK_Logo uuid:b8e625f8-f693-954f-a1f3-e51325a3fc6c uuid:150beb27-13bf-1c45-a39e-597feb062452 Adobe PDF library 15.00 endstream endobj 4215 0 obj > endobj 4216 0 obj >stream ����Adobed��C '# #+++ #-%'4/%-7/22B2/7:BBBBB:DDDDDDDDDDDDDDDDDDDDD��k�� PV��� ^C !"#$%&'()*123456789:ABCDEFGHIJQRSTUVWXYZabcdefghijqrstuvwxyz������ … �X�F�M��neԳ1 �xa�]� [1��O x��� �1���B1��ɴ0��n��3�㜶*�y��+y�a���P� vPvO�>��RfP��r�Z�?�� D�6,������Ѱ|4(�&d��!Tl�� ޗ�An,���� ��FU�y_ں��/C�OK�B%Q�%��� 9�3*y&x��K��:{+%�b֪�H��q�-]���3������H�/���� G��7��|H�*��XFoK��w"$��g�\��5:SVGL�p�y�+Ƅo�A`Tj��:M�/��!� !����8qe]� I�9��:"���-\��:��|i���B:�Z�At�e����|xi�(OZ�H�S����jWI2|в�RZWL�O�� A/�%n)�=�jg,���iqe�I�-o�j�1�;.�D?�����yJ�Y×2z1�7,�|)x�KIy��L�}Qa �t6�a|�t1W�B�&S�� ;Qf`]�FƄ1\_d ˌ�"��s���X��� … ��^� 1��������g���O4L W��3N��t�/p���,f�^Hc�B�v��)Ţy������aôd�Ӆ�y� Nb�)RFp� 1����"3��*D���������M?c�� �/Jݛ8��Ź7o�� �Ts�oZT��ޞ�v��w`���erq ���h� �{%Kֺ_�!4�~�[E� ̉;��YD��¥D>�髾��� ��c\U�O�yPͯ:�f��9��?�T6Z�\ GK�RS�Ee���e4�_{O�V���,����w�/���OuKj�n�:ppҷ���ϯ��Q�Q��5n���gc��E�����К]� �� �NIh�����Z�+����Ĺ�����Y�� ���+�N�
Pharma / Biotech archivos | Connectem ABOUT WHY CONNECTEM SERVICES TEAM INDUSTRY EXPERTISE IN VITRO DIAGNOSTIC MEDICAL DEVICES Clients CLIENTS TESTIMONIALS NEWS CONTACT Select Page Pharma / Biotech New collaboration with Finnish NADMED Ltd. Mar 20, 2024 | Pharma / Biotech We are excited to collaborate with Finnish NADMED Ltd., and introduce its new diagnostic kit for measuring NAD+ /... read more CPHI in Barcelona: Oncology projects ranging from medical. Oct 20, 2023 | Pharma / Biotech At CPhI Karim will be very keen to present interesting oncology projects ranging from medical nutrition to ne
NADMED successful in 3.5 million euro Series A round | Startbase Javascript is disabled in your browser Startbase requires Javascript in order to display content. Please check your browser settings and enable Javascript-Support for this website. Your browser is outdated and Startbase will not be displayed correctly. Please use a modern web-browser like Mozilla Firefox , Google Chrome , Safari or Microsoft Edge . Startbase.com Magazine News NADMED successful in 3.5 million euro Series A... Magazine Magazine Topic Overview News Ticker Venture Clienting Focus News Interviews Reports Portraits Kno … SI), with additional support from Voima Ventures and the University of Helsinki Fund. Importance of NAD and glutathione for medicine NAD and glutathione are crucial molecules for energy production, cell repair and growth in the body. An imbalance of these molecules is associated with numerous age-related diseases such as metabolic disorders, cancer, heart and brain diseases and muscle wasting. NADMED has developed a method to accurately and efficiently measure all four forms … AI Düsseldorf-based DeepTech startup aims to teach AI how to learn; TechVision Fund and neoteq invest in the continuous-learning AI. Marc Nemitz News 13 million euros for JUPUS More than 2,000 lawyers are already using the solution, which automates administrative tasks and can save law firms more than 70 hours of work each month. Marc Nemitz News Tsuga Raises $35 Million for Observability in the AI Era With $35 million in fresh capital, Tsuga aims to put control of telemetry … AI Düsseldorf-based DeepTech startup aims to teach AI how to learn; TechVision Fund and neoteq invest in the continuous-learning AI. Marc Nemitz News 13 million euros for JUPUS More than 2,000 lawyers are already using the solution, which automates administrative tasks and can save law firms more than 70 hours of work each month. Marc Nemitz Startbase.com Magazine News NADMED successful in 3.5 million euro Series A round Sign up About us Who we are Contact Knowledge Base Med
Revealing the Invisible: How NADMED Is Making Metabolism Measurable Programme Portfolio Mentors Partners Corporate Collaborators News Join NOME Home News Revealing the Invisible: How NADMED Is Making Metabolism Measurable Revealing the Invisible: How NADMED Is Making Metabolism Measurable Updates Portfolio companies August 12th, 2025 Revealing the Invisible: How NADMED Is Making Metabolism Measurable In healthcare and research, getting the right information at the right time can make all the difference. That’s exactly what Finnish biotech company NADMED is working to provide. By measuring key
Terkko Reaches A New Milestone! | Terkko Health Hub --> --> --> --> --> --> --> --> --> --> --> --> --> You are using an outdated browser. Please upgrade your browser to improve your experience. The Hub Members R2B Members Alumni Enablers Partners Innovation Actors Conferences Collaborators Other Actors For Students Startup Deep Dive Health and Life Sciences Career Fair For Researchers For Startups Become a Member Meeting Rooms Community Events New Nordics Healthtech Matchmaking Host Your Event Contact Us Become a Member The Hub Members R2B Members Alumni Enablers Partners Innovation Actors Co
NAD Assay Kits & Laboratory Service Home Products ALL PRODUCTS Q40 NAD+ & NADH Blood Kit (CE) Q16 NAD+ & NADH Small Blood Kit (CE) Q40 NAD+ & NADH Blood Kit (RUO) Q16 NAD+ & NADH Small Blood Kit (RUO) Q40 NAD+ & NADH Tissue/Cells Kit (RUO) Q40 NADP+ & NADPH Blood Kit (RUO) Laboratory service Science SCIENCE Nadmed Research Further reading Metabolites METABOLITES Clinical applications Why measure WHY MEASURE Clinical applications Partners News Contact Support About Us ABOUT US Media kit Nadmed as Business Products and Services shop Assay Kits NADMED offers a ra
%PDF-1.4 %���� 1 0 obj > endobj 3 0 obj > endobj 6 0 obj > stream x����r۸�6Z]J��Щ�qz���g�;����Z K��̓�8�l� @��Vת�}ݖx|�/6�����O��Ss��\��?T�����?�����M��Uk�aw�D?8r��M_�Oۛ��E��S����:�o Q _������V�T��(ܾ��m� ;��8��گ��T�S(����q{e���%?77V!\OE91�2=����%'?K7��.j��rn�j\�qI�Q#?o�����~��9��-9�_�)���G P�Ӝ ������M�^MM?Z�r��9�*Z~6z-5�hJ��F`E�ϭ�����r�y��������x�y����e �h2zln��� \�sӭP�����hry�W嶰`x���� ����J\Q� ��ۂ���=��/�_��`f�}|o��w�@/�b -�lNˣdK���� φ�_��` ZmD���y�A��R*eE ��ʽ���r����QG���˩�Y��X �C���}h@� >�]���M���vgty�����|�� ���슬����s�Uv~6���}P@� >/���ϛ~"�
NADMED attends Slush 2022 - Nadmed Ltd Home Products ALL PRODUCTS Q40 NAD+ & NADH Blood Kit (CE) Q16 NAD+ & NADH Small Blood Kit (CE) Q40 NAD+ & NADH Blood Kit (RUO) Q16 NAD+ & NADH Small Blood Kit (RUO) Q40 NAD+ & NADH Tissue/Cells Kit (RUO) Q40 NADP+ & NADPH Blood Kit (RUO) Laboratory service Science SCIENCE Nadmed Research Further reading Metabolites METABOLITES Clinical applications Why measure WHY MEASURE Clinical applications Partners News Contact Support About Us ABOUT US Media kit Nadmed as Business NADMED attends Slush 2022 by amandavisuals | Nov 11, 2022
%PDF-1.4 %���� 1 0 obj > endobj 3 0 obj > endobj 6 0 obj > stream x����r۸�6Z]J��Щ�qz���g�;����Z K��̓�8�l� @��Vת�}ݖx|�/6�����O��Ss��\��?T�����?�����M��Uk�aw�D?8r��M_�Oۛ��E��S����:�o Q _������V�T��(ܾ��m� ;��8��گ��T�S(����q{e���%?77V!\OE91�2=����%'?K7��.j��rn�j\�qI�Q#?o�����~��9��-9�_�)���G P�Ӝ ������M�^MM?Z�r��9�*Z~6z-5�hJ��F`E�ϭ�����r�y��������x�y����e �h2zln��� \�sӭP�����hry�W嶰`x���� ����J\Q� ��ۂ���=��/�_��`f�}|o��w�@/�b -�lNˣdK���� φ�_��` ZmD���y�A��R*eE ��ʽ���r����QG���˩�Y��X �C���}h@� >�]���M���vgty�����|�� ���슬����s�Uv~6���}P@� >/���ϛ~"�
New Research Links NAD Balance to Reversal of Alzheimer’s Pathology and Full Cognitive Recovery in Animal Models | FirstWord HEALTHTECH You need to enable JavaScript to run this app. Loading...
NAD Measuring for Laboratories Fast, Accurate, and Cost-effective Nad measuring for laboratories With the NADMED method, accurately measure NADs from blood samples using our CE-marked laboratory assay kit. Previously, mass spectrometry has been the only reliable method, albeit expensive and cumbersome. Now, NADMED offers a high-throughput solution, surpassing all others in all aspects to meet the growing demand for NAD measuring. Trusted by: + more than 80 companies / organizations in more than 20 countries How NADMED Method Outweighs Mass Speck? Read the Case Study. Work email SUBMIT Δ B … r. 4 hours. Time and Money Savings with NADMED. Read the Case Study. Work email SUBMIT Δ By sending this message I agree with NADMED Privacy Policy . Why Measure NADS? Bodily B3 vitamins manifest as NADs (nicotinamide adenine dinucleotide). NADs serve as general biomarkers of a person’s metabolic health. Changes in NAD levels indicate an imbalance in metabolism, often manifesting in disturbed energy status and/or regulatory capacity of the body. NAD levels give vita … eases. Clinical Applications Behind the Growing Interest. Read More. Work email SUBMIT Δ By sending this message I agree with NADMED Privacy Policy . { ”As the largest biological age testing laboratory in the US, we had always wanted to test for this important metabolite. However, the US market did not have an accurate lab test available. That is why we were excited to see the work and resume of NADMED. NADMED had studies showing reliability versus the gold standard … termine metabolite concentration. Take a Look at the Assay Workflow. Work email SUBMIT Δ By sending this message I agree with NADMED Privacy Policy . Contact Joonas Vaahtera Head of Business Development tel. +358 50 537 1339 [email protected] Read more: www.nadmed.com Contact NADMED team OFFICE NADMED Ltd. c/o Terkko Health Hub Haartmaninkatu 4, Building 14 00290 Helsinki – FINLAND LABORATORY NADMED Ltd. / Laboratory Biomedicum 1 Haartmaninkatu 8 00290
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
The Science Behind NADMED Home Products ALL PRODUCTS Q40 NAD+ & NADH Blood Kit (CE) Q16 NAD+ & NADH Small Blood Kit (CE) Q40 NAD+ & NADH Blood Kit (RUO) Q16 NAD+ & NADH Small Blood Kit (RUO) Q40 NAD+ & NADH Tissue/Cells Kit (RUO) Q40 NADP+ & NADPH Blood Kit (RUO) Laboratory service Science SCIENCE Nadmed Research Further reading Metabolites METABOLITES Clinical applications Why measure WHY MEASURE Clinical applications Partners News Contact Support About Us ABOUT US Media kit Nadmed as Business Science Behind NADMED Nadmed Research Further reading Non-destructive
NADMED Secures €3.5M to Accelerate International Sales Expansion - Nadmed Ltd Home Products ALL PRODUCTS Q40 NAD+ & NADH Blood Kit (CE) Q16 NAD+ & NADH Small Blood Kit (CE) Q40 NAD+ & NADH Blood Kit (RUO) Q16 NAD+ & NADH Small Blood Kit (RUO) Q40 NAD+ & NADH Tissue/Cells Kit (RUO) Q40 NADP+ & NADPH Blood Kit (RUO) Laboratory service Science SCIENCE Nadmed Research Further reading Metabolites METABOLITES Clinical applications Why measure WHY MEASURE Clinical applications Partners News Contact Support About Us ABOUT US Media kit Nadmed as Business NADMED Secures €3. … niversity of Helsinki Funds, from a number of private European investors, and a grant from Business Finland. Read more here . Search for: NADMED Ltd. Biomedicum 2U Tukholmankatu 8 00290 Helsinki FINLAND Office +358 (0)10 375 1180 [email protected] Laboratory +358 (0)10 375 1181 [email protected] IN COLLABORATION WITH Copyright 2026 NADMED | Business ID: FI3259265 – 3 | Privacy policy Website: Amanda Visuals | Pete Productions
The Longevity Global Summit 2025 · Zoom · Luma Discover Events Sign In Presented by Longevity Global Follow Connecting longevity researchers, investors, and entrepreneurs. Hosted By Christin Glorioso Mary Boyajian Justin Taylor Stephanie Lindstrom 525 Went Vicky Tong, Heather Quigley and 523 others Contact the Host Report Event The Longevity Global Summit 2025 Longevity Global Zoom Get Tickets Past Event Welcome! Please choose your desired ticket type: Early Bird 3 Left Sales ended General Admission VIP Includes an exclusive dinner with the Summit speakers, investors, and the press after day … tures), Robert Cargill (Quadrascope Ventures), Lisa Lambie, MBA (Maroon Venture Fund) 3:20 pm Pitch Competition 1. David Scieszka, PhD (Vertical Longevity Pharma) 2. Irit Rappley, PhD (NNP Laboratories) 3. Erika Chen, MS (Yunara Life) 4. Laura Glickman, PhD (Adjuvia Therapeutics) 5. Jernej Murn, PhD (StopTime) 6. Michael French, MS (Amaro Therapeutics) 7. Reena Bhargava, MD (BioTrax AI) 8. Peter Licari, PhD ( Animate Biosciences ) 9. Benedetta Di Robilant, PhD (ProMind Ther
Changing Faces: Digital and supplier hires – April 2026 | pharmaphorum Skip to main content Thursday 25 June 2026 BlueSky linkedin youtube header links Get Newsletters Media Kit Pharmaphorum menu first category News Views & Analysis Deep Dive Equity and Sustainability Research & Development Market Access Oncology Artificial Intelligence Patients & Partnerships GLP-1 Previous Editions Webinars Podcasts Videos Spotlight on ASCO BIO-Europe C-Suite Innovators ESMO Frontiers Health JP Morgan Global Policy Insights Events close SECTION News Views & Analysis Deep Dive Research & D … e sciences and co‑founder of McKinsey’s Scientific AI service line, driving the application of causal machine learning and advanced analytics across biopharma R&D. Valo Health leverages AI‑enabled human causal biology and closed‑loop chemistry platforms to support drug discovery and development. Alloy Therapeutics added a new AI‑enabled function with the appointment of Dr Alexander Titus to lead its newly formed Vigilance Division, focused on enhancing biosecurity prepare
NADMED Partnership Brings NAD Redox Testing to UK | Adam Shellard posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to … dividualized treatment strategies to reduce the global burden of heart disease. Submit your related work on our email here: [email protected] #HeartHealth #CardiovascularResearch #Genomics #PrecisionMedicine #ClinicalResearch #CoronaryArteryDisease #MedicalInnovation #PreventiveHealthcare #PersonalizedMedicine #Healthcare #PublicHealth #Biotech #LifeSciences 13 1 Comment Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in Rajinde … dividualized treatment strategies to reduce the global burden of heart disease. Submit your related work on our email here: [email protected] #HeartHealth #CardiovascularResearch #Genomics #PrecisionMedicine #ClinicalResearch #CoronaryArteryDisease #MedicalInnovation #PreventiveHealthcare #PersonalizedMedicine #Healthcare #PublicHealth #Biotech #LifeSciences 8 Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in Miguel Quintela-Fa
Prof. Sanguinetti's testimonial | bioMérieux Clinical Diagnostics (IVD) LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agree
Biotech NADMED raises €3.5M series A for 'NAD' vitals testing - Tech.eu News News Videos Insights: Premium articles Subscribe to Newsletters Topics Fintech Healthtech SaaS Deeptech Mobility Sustainability Artificial Intelligence Insights Tech.eu Insights Premium articles Reports Podcasts Funding Explorer Summit London 2026 --> NOTIFICATIONS Sign in to your account, or Sign up to stay up to date with the hottest European tech startup news. Sign in Sign up Search on Tech.eu... News News Videos Insights: Premium articles Funding Explorer Subscribe to Newsletters Topics Fintech Healthtec … s first full-year profit, amid challenging 2025 Blue Lake VC closes in on first fund with British Business Bank backing for immigrant-led startups French health insurance outfit Alan agrees €480M funding round Discover More About the Tech.eu Summit London 2026 --> Discover More About the Tech.eu Summit London 2026 --> Keep the pulse of the technology world with the Tech.eu Newsletter. Subscribe Dark Theme Tech.eu Insights creates insight and guides strategies with its compreh … niversity of Helsinki Funds, from a number of private European investors, and a grant from Business Finland. The round will fund its entry into the U.S. and other international markets with its proprietary nicotinamide adenine dinucleotide (NAD) measurement technology that may help clinicians establish more precise and personalized treatments for various diseases. The Helsinki-based company developed the first test to measure all four bodily forms of vitamin B3, called NADs,
Voima Ventures to back NADMED - Nadmed Ltd Home Products ALL PRODUCTS Q40 NAD+ & NADH Blood Kit (CE) Q16 NAD+ & NADH Small Blood Kit (CE) Q40 NAD+ & NADH Blood Kit (RUO) Q16 NAD+ & NADH Small Blood Kit (RUO) Q40 NAD+ & NADH Tissue/Cells Kit (RUO) Q40 NADP+ & NADPH Blood Kit (RUO) Laboratory service Science SCIENCE Nadmed Research Further reading Metabolites METABOLITES Clinical applications Why measure WHY MEASURE Clinical applications Partners News Contact Support About Us ABOUT US Media kit Nadmed as Business Voima Ventures to back NADMED by amandavisuals | Oct … y completed its first financing round of half a million euros, led by deep tech fund Voima Ventures. Other investors include individuals and members of the company’s executive management and board of directors. Read more: https://voimaventures.com/nadmed-investment-news/ Search for: NADMED Ltd. Biomedicum 2U Tukholmankatu 8 00290 Helsinki FINLAND Office +358 (0)10 375 1180 [email protected] Laboratory +358 (0)10 375 1181 [email protected] IN COLLABORATION WITH Copyright 202
NADMED Partners with London-based Altheome Labs - Nadmed Ltd Home Products ALL PRODUCTS Q40 NAD+ & NADH Blood Kit (CE) Q16 NAD+ & NADH Small Blood Kit (CE) Q40 NAD+ & NADH Blood Kit (RUO) Q16 NAD+ & NADH Small Blood Kit (RUO) Q40 NAD+ & NADH Tissue/Cells Kit (RUO) Q40 NADP+ & NADPH Blood Kit (RUO) Laboratory service Science SCIENCE Nadmed Research Further reading Metabolites METABOLITES Clinical applications Why measure WHY MEASURE Clinical applications Partners News Contact Support About Us ABOUT US Media kit Nadmed as Business NADMED Partners with London-based A
News - Nadmed Ltd NADMED Selected for US Market Entry Program in Collaboration with Mayo Clinic by Kai Herdin | Sep 12, 2025 | News NADMED has been selected to join the prestigious AMPlify program, a U.S. market entry initiative jointly organized by Mayo Clinic and Business Finland. The program combines world-class clinical expertise, valuable market knowledge, and extensive networks to support... Affinity Joins NADMED Network in London by Kai Herdin | Mar 4, 2025 | News Affinity Biomarker Labs, based in London, UK, is the latest partner to join the NADMED network, offering NAD+ and NADH testi … niversity of Helsinki Funds, from a number of private European investors, and a grant... Research Calls for Controlled Dosing of NAD-boosters by amandavisuals | Feb 21, 2024 | News A study involving a healthy population of 1162 individuals revealed that persistent high niacin intake, whether through fortified foods or supplements, raises the risk of cardiovascular disease by elevating the metabolite 4PY. The study further suggests that similar... High NAD amounts slow growth
Altheome Launches with NADMED Ltd. in UK | Altheome posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s Use … 6GZr 🤝 Interested in joining the IndoUSrare Corporate Alliance? Learn more and submit your interest here: http://bit.ly/4nZL0ln 💬 What areas of collaboration do you believe can have the greatest impact on rare disease patients globally? Harsha K Rajasimha , Narayanan Govindarajan , Reena Kartha , Nisha Venugopal , Ramya T karur , Indo US Organization for Rare Diseases (IndoUSrare) , Sreenithaa Muthuvel Velayuthasami , Shahzann Abaadi Dadachanji , Anish Bhatnagar , Juhi Nait
#nad #nadmed #altheome #nadtest | NADMED Ltd. LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement , Privacy Policy , and Co
Confirmed Exhibitors | ICNMD 2026 Skip to content ICNMD 2026 #ICNMD2026 SUBSCRIBE TO MAILING LIST Facebook-f X-twitter Linkedin About Message from the President About ICNMD ICNMD 2026 Committees Congress Secretariat Host Venue Related Events & Partners Past Congresses Future Congresses Contact Program CME Accreditation Program at a Glance Onsite Information Scientific Program Presenter Guidelines Call For Abstracts Patient’s Day Teaching Courses Joint Sessions Registration & Accommodation Registration Accommodation Social Events Sponsorship & Exhibits Sponsorship & Exhibit … n the scientific world, which consists of organising and financing workshops on application basis. enmc.org/ FSHD Society FSHD Society The FSHD Society is the world’s leading patient-driven organization dedicated to facioscapulohumeral muscular dystrophy (FSHD). We accelerate research, improve care, empower patients and families, and build community worldwide. Through education, advocacy, and collaboration, we work to bring effective treatments and a cure to everyone affected
The talk of Dr Liliya Euro was picked up as a highlight of the conference National University of Singapore Academy of Healthy Longevity. Liliya, a senior scientist from my lab and CSO of NADMED… | Anu Suomalainen Wartiovaara LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your c